Dilraj Lama

Karolinska Institutet — Sweden

Medicine · Health Sciences

16h-index689citations95works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tissue Engineering and Regenerative Medicine(16), Bladder and Urothelial Cancer Treatments(14), Click Chemistry and Applications(14), RNA and protein synthesis mechanisms(13), Advanced Breast Cancer Therapies(13)

Publications95 total

BPS2026 – Intrinsically disordered conserved motifs of c-MYC encode selective protein interactions
Biophysical Journal·2026
Liquid-liquid phase separation of tau regulates client binding <i>via</i> a conformational relay
2026Open Access
Conformational modulation of intrinsically disordered transactivation domains for cancer therapy
PNAS Nexus·2025· 1 citedOpen Access
Necroptotic Suppression of Lung Cancer Cell Proliferation and Migration: A Comprehensive In Vitro and In Silico Study to Determine New Molecular Targets for Pexidartinib
Cell Biochemistry and Function·2025· 5 citedOpen Access
BPS2025 - Modulation of c-MYC structure and activity by targeting a conformational switch
Biophysical Journal·2025
Native Mass Spectrometry Captures the Conformational Plasticity of Proteins with Low-Complexity Domains
JACS Au·2025· 6 citedOpen Access
AlphaFold with conformational sampling reveals the structural landscape of homorepeats
Structure·2024· 4 citedOpen Access
A druggable conformational switch in the c-MYC transactivation domain
Nature Communications·2024· 26 citedOpen Access
Mass Spectrometry of RNA-Binding Proteins during Liquid–Liquid Phase Separation Reveals Distinct Assembly Mechanisms and Droplet Architectures
Journal of the American Chemical Society·2023· 25 citedOpen Access
Liquid–Liquid Phase Separation Primes Spider Silk Proteins for Fiber Formation via a Conditional Sticker Domain
Nano Letters·2023· 54 citedOpen Access
Figure S1 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Table S1 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Supplementary Data from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Figure S2 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Data from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Figure S5 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Figure S9 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Data from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Table S1 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
Figure S6 from The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth &lt;i&gt;In Vivo&lt;/i&gt; and Potentiates Radiotherapy
2023Open Access
page 1 of 5Next →

Frequent Co-authors

David P. Lane(21), Chandra Verma(19), Christopher J. Brown(11), Michael Landreh(11), Prasanna Vasudevan Iyengar(9), Tuan Zea Tan(8), Peter ten Dijke(8), Cagla Sahin(8), Anna Rising(6), Ramasubbu Sankararamakrishnan(6), Dieuwke L. Marvin(6), Sudha Suriyamurthy(6), Maarten van Dinther(6), Hailiang Mei(6), Long Zhang(6), Laila Ritsma(6), Marie Arsenian‐Henriksson(6), Nicolas Fritz(6), Saikiran K. Sedimbi(6), Erik G. Marklund(5)